Suchergebnisse - "Desai, Neelam V"

PubPharm (16)

1

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer

enthalten in: JCO precision oncology | 2023

von Desai, N. | Barrows, E. | Nielsen, S. | +8

2

Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer : Single-Arm Prospective Clinical Trial

enthalten in: Journal of the American College of Surgeons | 2023

von Weiss, A. | Li, T. | Desai, N. | +20

CommentIn: J Am Coll Surg. 2023 Aug 1;237(2):256-258. - PMID 37199440

3

Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline BRCA1/2-Mutated Breast Cancers in the High-Risk, Early-Stage Setting

enthalten in: JCO precision oncology | 2023

von Desai, N. | Tan, A.

4

Q and A : A New Standard of Care for Germline BRCA1 and/or BRCA2 Mutation Carriers With Early-Stage Breast Cancer

enthalten in: JCO oncology practice | 2022

von Desai, N. | Zakalik, D. | Somerfield, M. | +1

5

A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer

enthalten in: NPJ breast cancer | 2022

von Waks, A. | Desai, N. | Li, T. | +18

6

Germline genetic testing in breast cancer : Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years

enthalten in: Cancer | 2021

von Desai, N. | Yadav, S. | Batalini, F. | +2

7

Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier

enthalten in: The breast journal | 2020

von Desai, N. | Tung, N.

8

Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier

enthalten in: The breast journal | 2020

von Desai, N. | Tung, N.

9

Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay

enthalten in: Breast cancer research : BCR | 2018

von Desai, N. | Torous, V. | Parker, J. | +6

10

Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay

enthalten in: Breast cancer research | 2018

von Desai, N. | Torous, V. | Parker, J. | +6